Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RIGL Rigel Pharmaceuticals

未开盘 04-24 16:00:00 EDT

1.13

-0.01

-1.32%

盘后1.13

+0.00+0.44%

18:51 EDT

最高1.16	最低1.11	成交量645.08万
今开1.13	昨收1.14	日振幅4.04%
总市值1.97亿	流通市值1.65亿	总股本1.75亿
成交额728.88万	换手率4.39%	流通股本1.47亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RIGL","market":"US","secType":"STK","nameCN":"Rigel Pharmaceuticals","latestPrice":1.125,"timestamp":1713988800000,"preClose":1.14,"halted":0,"volume":6450770,"hourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.125,"latestTime":"18:51 EDT","volume":5782662,"amount":6505510.7,"timestamp":1713999074461},"delay":0,"floatShares":146955996,"shares":175377812,"eps":-0.144187,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.015,"latestTime":"04-24 16:00:00 EDT","open":1.13,"high":1.156,"low":1.11,"amount":7288765.017774,"amplitude":0.040351,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.144187,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714032000000},"adr":0,"listingDate":975474000000,"adjPreClose":1.14,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.14,"latestTime":"08:00 EDT","volume":3023,"amount":3446.7529549,"timestamp":1713960049463},"postHourTrading":{"tag":"盘后","latestPrice":1.13,"preClose":1.125,"latestTime":"18:51 EDT","volume":5782662,"amount":6505510.7,"timestamp":1713999074461},"volumeRatio":4.971011},"requestUrl":"/m/hq/s/RIGL?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2429970379","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429970379","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429970379?lang=zh_cn&edition=full","pubTime":"2024-04-23 02:17","pubTimestamp":1713809843,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日02时17分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.19%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.03%。其相关个股中，Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大，Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃，换手率分别为198.68%、118.17%、88.40%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.，振幅分别为252.97%、82.14%、68.75%。Rigel Pharmaceuticals, Inc.公司简介：里格尔制药有限公司开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042302172387e8291c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042302172387e8291c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428544936","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大跌5.41%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428544936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428544936?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:55","pubTimestamp":1713470102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时55分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.41%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。Astra 全面负责开发和销售该药物，并将支付 Rigel 特许权使用费和里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419035502861e722e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419035502861e722e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427884558","title":"Rigel Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427884558","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427884558?lang=zh_cn&edition=full","pubTime":"2024-04-16 01:27","pubTimestamp":1713202040,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日01时27分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.00%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。Astra 全面负责开发和销售该药物，并将支付 Rigel 特许权使用费和里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160127207920a655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160127207920a655&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424698380","title":"美国研究综述-Biomea Fusion、贝莱德、Capital Bancorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2424698380","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424698380?lang=zh_cn&edition=full","pubTime":"2024-04-02 16:00","pubTimestamp":1712044801,"startTime":"0","endTime":"0","summary":"    路透社4月2日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Biomea Fusion、贝莱德和 Capital Bancorp。要闻 * Biomea Fusion Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性 * 贝莱德  ：摩根大通将目标价从742美元上调至767美元 * Capital Bancorp Inc   ：斯蒂芬斯将其评级从 \"等权重 \"上调至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422439339","title":"Rigel Pharmaceuticals, Inc.盘中异动 急速上涨5.63%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422439339","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422439339?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:32","pubTimestamp":1711557146,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时32分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.63%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3272.09%、1212.11%、75.11%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.，振幅分别为86.96%、78.00%、59.87%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003227861e1b9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328003227861e1b9e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419970388","title":"Rigel Pharmaceuticals, Inc.盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419970388","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419970388?lang=zh_cn&edition=full","pubTime":"2024-03-15 22:22","pubTimestamp":1710512532,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日22时22分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.26%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Better Therapeutics, Inc.、杰龙、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为234.38%、72.52%、21.93%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为94.29%、63.00%、49.00%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031522221287e795e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031522221287e795e7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419600675","title":"Rigel Pharmaceuticals, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419600675","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419600675?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:12","pubTimestamp":1710425532,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日22时12分，Rigel Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.17%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为446.21%、139.96%、68.15%，振幅较大的相关个股有知临集团、Nuvectis Pharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为76.91%、46.47%、41.94%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314221213861de410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314221213861de410&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418643110","title":"Rigel Pharmaceuticals, Inc.2023财年实现净利润-25.09百万美元，同比增加57.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418643110","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418643110?lang=zh_cn&edition=full","pubTime":"2024-03-09 00:25","pubTimestamp":1709915130,"startTime":"0","endTime":"0","summary":"12月31日，Rigel Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为-25.09百万美元，同比增加57.16%；其中营业收入为1.17亿美元，同比减少2.50%，每股基本收益为-0.14美元。从资产负债表来看，Rigel Pharmaceuticals, Inc.总负债1.46亿美元，其中短期债务7.92百万美元，资产负债比为0.81，流动比率为1.87。机构评级：截至2023年12月31日，当前有6家机构对Rigel Pharmaceuticals, Inc.目标价做出预测，其中目标均价为4.46美元，其中最低目标价为1.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030900253787662d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030900253787662d2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417292177","title":"Rigel Pharmaceuticals, Inc.盘中异动 快速拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417292177","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417292177?lang=zh_cn&edition=full","pubTime":"2024-03-06 22:30","pubTimestamp":1709735450,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日22时30分，Rigel Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.41%。Rigel Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.35%。其相关个股中，Biomx Inc.、知临集团、Nkgen Biotech, Inc.涨幅较大，Creative Medical Technology Holdings, Inc.、Biomx Inc.、知临集团较为活跃，换手率分别为149.09%、106.17%、82.75%，振幅较大的相关个股有Biomx Inc.、知临集团、Creative Medical Technology Holdings, Inc.，振幅分别为25.96%、24.14%、7.76%。Rigel Pharmaceuticals, Inc.公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306223050861dbd28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306223050861dbd28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416770836","title":"Rigel Pharmaceuticals Inc    预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2416770836","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416770836?lang=zh_cn&edition=full","pubTime":"2024-03-02 06:05","pubTimestamp":1709330707,"startTime":"0","endTime":"0","summary":"   * Rigel Pharmaceuticals Inc    将于3月5日公布截至2023年12月31日的季度业绩，预计该公司的季度收入将出现下降。* LSEG 分析师对 Rigel Pharmaceuticals Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Rigel Pharmaceuticals Inc 的 12 个月目标价中位数为 2.00 美元，高于上一次收盘价 1.52 美元。3月1日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414819803","title":"Rigel Pharmaceuticals Inc盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414819803","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414819803?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:35","pubTimestamp":1709044517,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时35分，Rigel Pharmaceuticals Inc股票出现波动，股价急速上涨5.28%。Rigel Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为321.44%、88.49%、29.77%，振幅较大的相关个股有Janux Therapeutics Inc、Viking Therapeutics Inc、Fate Therapeutics，振幅分别为36.62%、25.26%、17.84%。Rigel Pharmaceuticals Inc公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722351887e739bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022722351887e739bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414074158","title":"美国研究综述-Elf Beauty、Moderna、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2414074158","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414074158?lang=zh_cn&edition=full","pubTime":"2024-02-26 15:57","pubTimestamp":1708934231,"startTime":"0","endTime":"0","summary":"    路透社2月26日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Elf Beauty、Moderna 和 Zscaler。要点             * 精灵美容公司  ：Piper Sandler将目标价从212美元上调至225美元             * Moderna   ：汇丰银行将目标价从持有下调至减持              * Zscaler Inc   ：摩根大通将目标价从212美元上调至240美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413624820","title":"嗡嗡声--美国股票走势-Wayfair Inc、Remitly Global、Monopar Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2413624820","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413624820?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:55","pubTimestamp":1708617309,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月22日 - 在英伟达的出色业绩和预测刺激了今年人工智能引领的涨势之后，基准标普500指数周四短暂创下新纪录。美东时间10:31，道琼斯工业平均指数  上涨0.71%，报38888.1点。标准普尔500指数  上涨1.62%，报5062.63点；纳斯达克综合指数  上涨2.43%，报15959.39点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413921716","title":"BUZZ-Rigel 制药公司获得肺癌药物美国销售权后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2413921716","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413921716?lang=zh_cn&edition=full","pubTime":"2024-02-22 23:29","pubTimestamp":1708615754,"startTime":"0","endTime":"0","summary":"    2月22日 - ** 制药商Rigel Pharmaceuticals   股价上涨4.9%，至1.17美元 ** 公司将从 Blueprint Medicines    公司获得  肺癌药物 Gavreto 在美国的销售权。根据协议，RIGL 将向 Blueprint 支付 1,500 万美元，其中 1,000 万美元在该药物首次商业销售时支付，另外 500 万美元在交易完成日期一周年时支付。** 过去12个月里，Rigel公司股价下跌了27.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411589115","title":"Rigel Pharmaceuticals Inc盘中异动 临近午盘快速上涨5.00%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411589115","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411589115?lang=zh_cn&edition=full","pubTime":"2024-02-15 00:55","pubTimestamp":1707929752,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日00时55分，Rigel Pharmaceuticals Inc股票出现异动，股价急速上涨5.00%。截至发稿，该股报1.18美元/股，成交量18.1266万股，换手率0.10%，振幅4.02%。Rigel Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.55%。Rigel Pharmaceuticals Inc公司简介：Rigel Pharmaceuticals Inc 开发用于自身免疫性疾病、癌症相关疾病和病毒性疾病的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215005552861d540e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215005552861d540e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rigel.com","stockEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":-0.2187},{"period":"3month","weight":-0.1},{"period":"6month","weight":0.5407},{"period":"1year","weight":-0.0044},{"period":"ytd","weight":-0.2241}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rigel Pharmaceuticals, Inc.于1996年6月14日成立于特拉华州。该公司是一家生物技术公司，致力于发现、开发和提供新疗法，显著改善血液系统疾病和癌症患者的生活。公司首个获FDA批准的产品是TAVALISSE（六水二钠福司他马替尼）片，这是唯一获批的口服脾脏酪氨酸激酶（SYK）抑制剂，用于治疗对先前治疗反应不足的慢性免疫性血小板减少症（ITP）成人患者。该公司第二个获得FDA批准的产品是REZLIDHIA（olutasidenib）胶囊，用于治疗经FDA批准的试验检测出具有易感异柠檬酸脱氢酶-1（IDH1）突变的复发或难治性（R/R）急性髓系白血病（AML）成人患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.027089},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.035362},{"month":3,"riseRate":0.541667,"avgChangeRate":0.022379},{"month":4,"riseRate":0.5,"avgChangeRate":0.027633},{"month":5,"riseRate":0.347826,"avgChangeRate":0.001838},{"month":6,"riseRate":0.434783,"avgChangeRate":0.016578},{"month":7,"riseRate":0.478261,"avgChangeRate":-0.016879},{"month":8,"riseRate":0.391304,"avgChangeRate":-0.008144},{"month":9,"riseRate":0.478261,"avgChangeRate":0.023958},{"month":10,"riseRate":0.391304,"avgChangeRate":-0.060551},{"month":11,"riseRate":0.391304,"avgChangeRate":0.017926},{"month":12,"riseRate":0.5,"avgChangeRate":0.1521}],"exchange":"NASDAQ","name":"Rigel Pharmaceuticals","nameEN":"Rigel Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rigel Pharmaceuticals,RIGL,Rigel Pharmaceuticals股票,Rigel Pharmaceuticals股票老虎,Rigel Pharmaceuticals股票老虎国际,Rigel Pharmaceuticals行情,Rigel Pharmaceuticals股票行情,Rigel Pharmaceuticals股价,Rigel Pharmaceuticals股市,Rigel Pharmaceuticals股票价格,Rigel Pharmaceuticals股票交易,Rigel Pharmaceuticals股票购买,Rigel Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rigel Pharmaceuticals(RIGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rigel Pharmaceuticals(RIGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}